AU4364700A - Triple hybrid amplicon vector systems to generate retroviral packaging lines - Google Patents

Triple hybrid amplicon vector systems to generate retroviral packaging lines

Info

Publication number
AU4364700A
AU4364700A AU43647/00A AU4364700A AU4364700A AU 4364700 A AU4364700 A AU 4364700A AU 43647/00 A AU43647/00 A AU 43647/00A AU 4364700 A AU4364700 A AU 4364700A AU 4364700 A AU4364700 A AU 4364700A
Authority
AU
Australia
Prior art keywords
vector systems
retroviral packaging
packaging lines
amplicon vector
triple hybrid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43647/00A
Other languages
English (en)
Inventor
Xandra O. Breakefield
Yoshinaga Saeki
Miguel Sena-Esteves
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of AU4364700A publication Critical patent/AU4364700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051Methods of production or purification of viral material
    • C12N2740/13052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU43647/00A 1999-04-22 2000-04-21 Triple hybrid amplicon vector systems to generate retroviral packaging lines Abandoned AU4364700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13055199P 1999-04-22 1999-04-22
US60130551 1999-04-22
PCT/US2000/010669 WO2000065077A1 (fr) 1999-04-22 2000-04-21 Systeme de vecteurs d'amplicons hybrides triples pour la generation de lignees d'encapsidation

Publications (1)

Publication Number Publication Date
AU4364700A true AU4364700A (en) 2000-11-10

Family

ID=22445216

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43647/00A Abandoned AU4364700A (en) 1999-04-22 2000-04-21 Triple hybrid amplicon vector systems to generate retroviral packaging lines

Country Status (3)

Country Link
EP (1) EP1179083A4 (fr)
AU (1) AU4364700A (fr)
WO (1) WO2000065077A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3380604B1 (fr) * 2015-11-24 2022-12-28 GlaxoSmithKline Intellectual Property Development Limited Lignees cellulaires stables pour la production de retrovirus
AU2016359838B2 (en) 2015-11-24 2020-08-06 Glaxosmithkline Intellectual Property Development Limited Transient transfection method for retroviral production

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830725A (en) * 1995-04-28 1998-11-03 The Board Of Trustees For The Leland Stanford Junior University Rapid, stable high-titre production of recombing retrovirus
US5830727A (en) * 1995-11-18 1998-11-03 Human Gene Therapy Research Institute Herpes simplex virus amplicon mini-vector gene transfer system
JP2002503086A (ja) * 1996-11-12 2002-01-29 ザ ジェネラル ホスピタル コーポレイション Hsv/aavハイブリッドアンプリコンベクター

Also Published As

Publication number Publication date
EP1179083A4 (fr) 2003-04-23
WO2000065077A8 (fr) 2001-10-11
EP1179083A1 (fr) 2002-02-13
WO2000065077A1 (fr) 2000-11-02

Similar Documents

Publication Publication Date Title
AU2112101A (en) Virtual second line hybrid network communication system
AU1779101A (en) Virtual pbx system
AU3854399A (en) Composite hybrid riser
AU7065100A (en) Integrated hybrid optoelectronic devices
AU2001265952A1 (en) Hybrid coating compositions
AU2001242433A1 (en) Hybrid well communication system
AU2675801A (en) Reclosable carton for powders
AU2926000A (en) Packaging cells for retroviral vectors
AU2599401A (en) Multiple compartment package design
AU1447601A (en) Product packaging arrangement having retainer
AU4955900A (en) Packaging comprising coupled boxes
AU2573199A (en) Spar system
AU3834200A (en) Reclosable packaging systems
AU2495300A (en) Lentivirus vector system
AU6461599A (en) Packaging for medicaments
AU6139699A (en) Packaging cell lines for hiv-derived retroviral vector particles
AU2842600A (en) System for direct communications with a space craft
AU3960999A (en) Catalyst system for ethylene polymerisations
AU4364700A (en) Triple hybrid amplicon vector systems to generate retroviral packaging lines
AU6489199A (en) Aerospace system
AU2001263683A1 (en) Inter-bay bipolar dc bus link
AU5780000A (en) Packaging controller for cushioning producing system
AU2367501A (en) Thermoformed closure for cartons
AU3666199A (en) Packaging machine with the capability to convert to different carton cross sections
AU5631699A (en) Atmospheric package for pasty product

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase